Seeing is Believing – The Edwards Mitral & Tricuspid Transcatheter Portfolio

Published: 11 November 2021

  • Views:

    Views Icon 5762

  • Likes:

    Heart Icon 7
Average (ratings)
No ratings
Your rating

Overview

This on-demand version of the broadcast "Seeing is Believing – The Edwards Mitral & Tricuspid Transcatheter Portfolio" sees event Chair Didier Tchétché (Clinic Pasteur, Toulouse, FR) joined by an internationally-respected panel, as they explore key elements of the PASCAL platform. Dr Sam Dawkins (John Radcliffe Hospital, UK) explores its practical application for MR, Dr Nicole Karam (European Hospital Georges Pompidou, FR) for TR; whilst Dr Andreas Ruck (Karolinska University Hospital, SE) provides additional insight with a case-based review of its successful, safe application for Tricuspid Valve repair. Prof Jörg Hausleiter (Ludwig-Maximilians Universitat, Munich, DE) looks to the future of TR treatment, with a review of the EVOQUE replacement system. Prof Michael Böhm provides insight from a heart failure perspective throughout the discussions.

 

The presentations and discussions are set against the back-drop of a live case from the Heart Center Leipzig, under the guidance with Prof Philipp Lurz with Prof Peter Ludike.

This programme was supported by

Learning objectives

  • To discuss the clinical evidence of PASCAL repair system in the treatment of MR and TR
  • To learn from case examples how the PASCAL repair system improves outcomes of patients with MR and TR
  • To participate in a step-by-step LIVE demonstration of percutaneous mitral leaflet repair with the PASCAL repair system

Audience

  • Interventional Cardiologists
  • Cardiologists

More from this programme

Part 1

Event Introduction and the PASCAL Platform for MR Treatment

Dr Didier Tchétchè provides a brief introduction to proceedings, including key features and applications of the PASCAL platform, before Dr Sam Dawkins examines the PASCAL platform's role in the treatment of Mitral Regurgitation.
1 session
Introduction and The Pascal Platform for MR Treatment Watch now

Part 2

PASCAL MR Live Case – Patient Presentation and Strategy

Prof Philipp Lurz and the Leipzig team are joined by Prof Peter Lüdike to outline patient presentation and discuss case strategy.
1 session
PASCAL MR Live Case – Patient Presentation and Strategy Watch now

Part 3

PASCAL Platform – Successful and Durable Treatment of MR

Dr Sam Dawkins returns to continue his review of the PASCAL platform for use in Mitral Regurgitation, presenting key data from the CLASP study, and a case example. He further reports on his single-centre experience.
1 session
PASCAL Platform – Successful and Durable Treatment of MR Watch now

Part 4

PASCAL MR Live Case and Panel Discussion

The studio panel rejoin Prof Philip Lurz, Prof Peter Lüdike and the rest of the Leipzig team for an update on the live case.
1 session
PASCAL MR Live Case and Panel Discussion Watch now

Part 5

The PASCAL Platform for TR Treatment

Dr Nicole Karam reviews the PASCAL platform for TR treatment, addressing significant clinical improvement in patients with challenging tricuspid anatomy, whilst drawing on German and Swiss multi-centre experience.
1 session
The PASCAL Platform for TR Treatment Watch now

Part 6

PASCAL Platform – Safe and Successful Treatment of TR

In a review of PASCAL's record of safe and effective treatment of Tricuspid Regurgitation, Dr Andreas Ruck shares experience for optimal results, including its ease to optimise and re-grasp, and the very low risk of leaflet or chordal damage.
1 session
PASCAL platform – Safe and Successful Treatment of TR Watch now

Part 7

Live Case Wrap-up and Panel Discussion

The panel rejoin Leipzig Heart Center for Prof Lurz's summary of the live case, whilst session Chair Didier Tchetche canvasses the opinions of the studio panel.
1 session
Live Case Wrap-up and Panel Discussion Watch now

Part 8

The Future of TR Treatment with the Tricuspid Replacement System, and Event Summary

Prof Jorg Hausleiter looks to the future of TR treatment, including examining the 6-month results of the TRISCEND study whilst sharing positive early experience with the EVOQUE transfemoral system. Session Chair Didier Tchetche discusses key learnings from the event.
1 session
The Future of TR Treatment With the Tricuspid Replacement System, and Summary Watch now

Faculty Biographies

Didier Tchétché

Didier Tchétché

Didier Tchétché, (Clinique Pasteur, Toulouse, France) Graduated from the University of Paris V where Dr Tchétché obtained his post-graduate diploma of cardiovascular pathology in 2004. From 2004 to 2005, he completed a 12-month fellowship period in the Hemodynamic and Interventional Cardiology department of Clinique Pasteur in Toulouse and from 2005 to 2007 he was Head Assistant at the intensive care unit of Bichât Hospital in Paris.

In 2008, he joined the interventional cardiovascular group in Clinique Pasteur, Toulouse, and he is currently Head of the Structural programme with an experience of more than 5000 TAVI procedures. His main areas of interest are coronary interventions and valvular heart disease. He has been actively involved in many clinical trials involving new technologies and devices in the field of interventional cardiology.

View full profile
Philipp Lurz

Philipp Lurz

University Medical Center Mainz, Mainz, Germany

Prof Philipp Lurz is Director of the Department of Cardiology Universitätsmedizin Mainz, Germany. Prior to this, he served as Deputy Head of the Department at Heart Center Leipzig, Germany. Previously, Prof Lurz was a Clinical Research Fellow at Great Ormond Street Hospital for Children NHS Foundation Trust. He completed his education at the University of Leipzig, and is a member of the German Society of Cardiology. Philipp is widely published in leading international peer-reviewed journals.

View full profile
Peter Lüdike

Peter Lüdike

Senior Physician

Prof Peter Lüdike is Senior Physician of the Heart Failure and Intensive Care section in the Department of Cardiology and Vascular Medicine at the West German Heart and Vascular Center, University Hospital Essen. He achieved Venia legendi for internal medicine in 2018 and was appointed as Full Professor for heart failure in 2020. His research interests include intensive care medicine, emergency medicine, heart failure, mitral valve disease and the role of macrophage migration inhibitory factor in the development of ischaemic heart disease.

View full profile